ADGI - Hot Stocks: Stay-at-home COVID therapy stocks surge; OCGN stumbles; PDD earnings; CARS sets high

The discovery of a new COVID-19 variant sparked a massive sell-off on Wall Street Friday, with the major averages each plunging more than 2%. However, some parts of the market benefitted from growing concern about a new wave of the virus. For example, stay-at-home stocks received renewed interest following acute selling pressure during much of 2021. Zoom Video (NASDAQ:ZM) and Peloton (NASDAQ:PTON) were among the highest-profile names that got a lift on Friday, with Alpha Pro Tech (NYSE:APT) and Teladoc Health (NYSE:TDOC) also posting notable gains. Meanwhile, companies involved in battling the pandemic saw a flood of buyers. Along with vaccine makers, smaller names, like iSpecimen (NASDAQ:ISPC), Adagio Therapeutics (NASDAQ:ADGI) and Vir Biotechnology (NASDAQ:VIR), finished the session with substantial gains. On the downside, COVID vaccine maker Ocugen (NASDAQ:OCGN) was left out of the rally. Rather, the stock posted a notable decline on a regulatory setback in the U.S. Meanwhile, Pinduoduo

For further details see:

Hot Stocks: Stay-at-home, COVID therapy stocks surge; OCGN stumbles; PDD earnings; CARS sets high